The antiproliferative effect of suramin on the cancer cell line SW-13 is mediated by the inhibition of transforming growth factor beta 1 (TGF-beta 1)

Pharmacol Res. 1992 Feb-Mar:25 Suppl 1:17-8. doi: 10.1016/1043-6618(92)90519-h.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Gland Neoplasms / genetics
  • Adrenal Gland Neoplasms / pathology*
  • Blotting, Northern
  • Cell Division / drug effects*
  • Gene Expression / drug effects
  • Humans
  • RNA, Messenger / genetics*
  • RNA, Messenger / metabolism
  • RNA, Neoplasm / genetics
  • RNA, Neoplasm / metabolism
  • Suramin / pharmacology*
  • Transforming Growth Factor beta / genetics*
  • Tumor Cells, Cultured
  • Tumor Stem Cell Assay

Substances

  • RNA, Messenger
  • RNA, Neoplasm
  • Transforming Growth Factor beta
  • Suramin